ThermoGenesis Announces Expanded Collaboration With Celling Technologies

... of SpineSmith, LLC, related to the Company's bone marrow products, MXP(TM) MarrowXpress(TM) ("MXP") and ... facilitates cryopreservation of processed bone marrow aspirates. The bone marrow concentrates are used in spinal fusion ....

ThermoGenesis Provides Update on Fiscal 2009 Results

... a point of care processing device for bone marrow aspirate to concentrate stem cells, was formally launched in July. The Res-Q System processes bone marrow in minutes and delivers a high rate of stem cell ... the market adoption of the Company's bone marrow processing technologies and increase Company ...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

... cells but permitted the regrowth of normal bone marrow cells within 42 days of treatment in a Rag2-M ... up in higher levels by leukemic cells in the bone marrow than by normal bone marrow cells. They concluded that the preferential ...

Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations

... ATIR(TM) showing its potential in mismatched bone marrow transplantations. Data was presented by ... Symposium at the Annual European Bone marrow Transplantation meeting (EBMT) in Goteborg, ... for early immune reconstitution following a bone marrow transplantation with a fully mismatched ...

ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference

... the efficiency of stem cell recovery from bone marrow following processing with the MXP and ... reduce and harvest stem cells from human bone marrow in a functionally closed system. Results ... efficient collection of stem cells from bone marrow aspirate and platelet rich plasma from whole ...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

... and Oncology. He began his training in bone marrow transplantation while in medical school, with ... Miami , focused on pediatric immunology and bone marrow transplantation. His research focus was in the ... with a clinical appointment on the Pediatric Bone marrow Transplant Service at the University of ...

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

... HIV infection and leukemia and received a bone marrow transplant from a donor carrying the CCR5 mutation. After the successful bone marrow transplant, HIV treatment was discontinued and ... occurring mutations in man and the recent bone marrow transplant report," commented Dale Ando, M.D., ...

Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer

... cell based therapeutics in the field of bone marrow transplantation, announces today the appointment ... Dr. Egeler is a global leading pediatric bone marrow transplantation physician and ... as Head of the Pediatric Oncology and Bone marrow Transplantation division of the University of ...

Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)

... enabling the use of a mismatched donor in a bone marrow transplantation by preventing acute Graft versus ... who is a leader in the field of mismatched bone marrow transplantations," says Dr. Manja Bouman, CEO of ... safe and potentially life-saving mismatched bone marrow transplantations as a treatment option for ...

StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists

... and other physicians specializing in bone marrow transplantation. "We are excited to develop ... to provide a new device to facilitate bone marrow harvest, with the goal of improving the donor ... is designed to rapidly and easily harvest bone marrow in a minimally invasive manner, in the outpatient ...

High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma

... an innovative study that investigated high (bone marrow ablative) dose Zevalin(R) ([90Y]-ibritumomab ... were noted with this regimen. The expected severe marrow suppression associated with myeloablative ... toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. ...

CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team

... President of the European Group of Bone marrow Transplantation (EBMT). During her 30 years as a ... Dr. Gluckman has performed over 1,900 bone marrow and cord blood transplants. "I am very honored ... Levine was responsible for initiating the bone marrow and umbilical cord blood research programs at the ...

Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.

... N.J., Oct. 2 /PRNewswire/ -- The Blood and marrow Stem Cell Transplantation Program at the John ... and healthcare organizations. The Blood and marrow Transplantation Program also recently became the ... high level of expertise offered by our Blood and marrow Stem Cell Transplantation Program's chief, Dr. ...

Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product

... therapy and, infrequently, bone marrow transplantations -- a procedure that carries ... nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002;100:3897-3902. (7) ... (8) Maciejewski, et al. Relationship between bone marrow failure syndromes and the presence of ...

Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants

... Researchers and clinicians at the Adult Blood and marrow Stem Cell Transplantation Program at The Cancer ... A New Paradigm for Designer Allogeneic Blood and marrow Transplantation," was co-authored by ... L. Donato, M.D., director of the Blood and marrow Collection Facility; and Scott D. Rowley, M.D., ...

Repair Stem Cell Institute Announces Science Advisory Board

... Professor Shimon Slavin, M.D., an expert bone marrow transplantation scientist and clinician, is ... stem cells) taken from their bone marrow and multiplied in culture. Dr. Slavin is the ... in RSC treatments, rejected traditional bone marrow stem cells as a too limited source for the ...

ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))

... APPLICATION WILL BE FOR USE IN POINT-OF-CARE BONE marrow PROCESSING RANCHO CORDOVA, Calif., July 14 ... William Osgood, Chief Executive Officer. Bone marrow derived stem cells are the dominant source of ... than twice these amounts. In addition, bone marrow stem cells are currently processed in a number of ...

Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

... intracellular uptake of LOR-2040 in the bone marrow leukemic cells, and identified significant accumulation of the drug in the bone marrow blast cells and suggested preferential uptake of ... drug by CD34+ cells, an important malignant bone marrow cell population. The authors concluded that ...

Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting

... In addition, within a subgroup in which bone marrow cells were examined before and after treatment, ... also showed the greatest increase in bone marrow stem cells. The trial was conducted by principal ... responders had the largest fold increase in bone marrow stem cells twelve days after dosing. Increased ...

StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform

... stem and progenitor cells it contains, for bone marrow transplantation. Additionally," he explained, ... to rapidly and easily harvest stem cell-rich bone marrow in a minimally-invasive manner, in the outpatient ... is in contrast to the current practice of bone marrow aspiration through the insertion of a large gauge ...

ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health

... AND STORAGE OF EQUINE CORD BLOOD, BONE marrow AND PLACENTAL TISSUE STEM CELLS RANCHO CORDOVA, ... of stem cells from equine cord blood, bone marrow and placental tissue. These cells will be used ... of bacterial-induced alterations in bone marrow proliferation and differentiation. She has ...

CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board

... Division of Hematology- Oncology and Blood and marrow Transplantation at the University of Minnesota. ... is the Director of the Pediatric Blood and marrow Program at Duke University and the Medical ... Levine was responsible for initiating the bone marrow and umbilical cord blood research programs at the ...

Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc

... of cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer ... improved overall survival after autologous bone marrow transplantation in Non-Hodgkin's lymphoma ... autologous transplant uses the patient's own bone marrow to serve as a graft. Bone-marrow transplants are ...

Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications

... material. The addition of autologous bone marrow further enhances the bone forming capability of ... material that is hydrated with autologous bone marrow at the point of use. OssiMend strips and pads can ... OssiMend, we are introducing a Multi-port Bone marrow Aspiration Needle to aid in the harvest of ...

PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials

... therapy and, infrequently, bone marrow transplantations -- a procedure that carries ... nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002;100:3897-3902. ... Maciejewski, et al. Relationship between bone marrow failure syndromes and the presence of ...

RSCI Announces World-Leading Stem Cell Science Advisory Board

... Professor Shimon Slavin, M.D., Deputy Chairman, is an expert bone marrow transplantation scientist and clinician, is famous for his innovative ... experts in stem cell treatments, rejected traditional bone marrow stem cells as a too-limited source for the neurological stem cells ...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... of side effects associated with ALIMTA therapy. ALIMTA can suppress bone marrow function. It is very important to take folic acid and vitamin B12 prior to ... tell your doctor you should not receive it. GEMZAR can suppress bone marrow function. There have been rare reports of serious kidney or liver toxicity ...

Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies

... Amniotic fluid (AF) cells that had markers similar to bone marrow stem cells (termed AFKL cells) were then isolated for use in experiments, ... ability of the transplanted cells to produce new blood cells. Bone marrow samples from the transplanted mice were also taken and injected in a ...

Renowned Stem Cell Researcher Files Study Results With Stemedica

... long term safety of adult stem cells in general and our mesenchymal bone marrow stem cell line in particular. Secondarily, study results clearly showcase ... osteonecrosis in relation to sickle cell disease to the use of bone marrow grafts in the treatment of delayed unions and non unions. Dr. Hernigou ...

International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"

... serum FLC measurements reduce the need for frequent, painful bone marrow biopsies; - for some intact immunoglobulin MM patients in remission, ... a condition known as myeloma. Myeloma cells gradually replace healthy bone marrow cells, leading to bone pain and infections. A patient with myeloma may ...

Transplant Program Tops in Expected One-Year Survival Rate

... over a five-year period. The Center for International Blood and marrow Transplant Registry examined the survival rates of 8,847 transplants performed to treat blood cancers at U.S. centers in the National marrow Donor Program (NMDP) network. The survival data was collected for the ...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

... non-specific immunosuppressive therapy and, infrequently, bone marrow transplantations -- a procedure that carries considerable mortality risk. ... Maciejewski JP, Risitano AM, Sloand EM, et al. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol- anchored ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... of side effects associated with ALIMTA therapy. ALIMTA can suppress bone marrow function. It is very important to take folic acid and vitamin B12 prior to ... tell your doctor you should not receive it. GEMZAR can suppress bone marrow function. There have been rare reports of serious kidney or liver toxicity ...

ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent

... device in the U.S. The MXP is used for concentrating stem cells from bone marrow at both the point-of-care and in a laboratory setting. "In addition, we ... that will offer stem cell laboratory services and point-of-care bone marrow and peripheral blood processing products focused initially on the ...

Sangamo BioSciences Reports Second Quarter 2008 Financial Results

... in the peripheral blood. In addition, within a subgroup in which bone marrow cells were examined before and after treatment, the data suggests that ... the tissues of the lower limbs, also showed the greatest increase in bone marrow stem cells. This observation of stem cell mobilization after treatment ...

ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)

... product in the European Community. The MXP device is used to process bone marrow in a laboratory setting. The MXP is a derivative of the Company's ... very encouraging feedback from a number of European centers at which bone marrow clinical trials are either underway or planned. With this approval, we can ...

Genzyme Files Applications for Approval of Mozobil in the United States and Europe

... Clinical Role Mozobil is designed to mobilize stem cells from the bone marrow into the bloodstream where they can be collected, making it more likely ... marrow. A stem cell transplant is required to replenish blood-forming bone marrow cells destroyed by high-dose chemotherapy. Stem cells differentiate into ...

Israeli Scientists Recipients of 2008 International Adult Stem Cell Award

... Margolis, WCASCE Chairman and Founder, "Professor Slavin is an expert bone marrow transplantation scientist and clinician. The former Director of Israel's ... of adult stem cells (mesenchymal stromal stem cells) taken from their bone marrow and multiplied in culture. Some of the patients' conditions have improved ...

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

... bone, demineralized bone matrix (DBM) and viable MSCs native to the marrow rich bone. Found in human bone marrow, MSCs are fundamental regenerative ... tissue. MSCs are believed to help regulate the behavior of other bone marrow cells. Alex Lukianov, Chairman and Chief Executive Officer, said, ...

JCI online early table of contents: March 6, 2008

... mutations in the SBDS gene and characterized by, among other things, bone marrow failure and an increased risk of acute myeloid leukemia. New insight into ... Boston and the University of Washington, Seattle, who analyzed human bone marrow stromal cells (BMSCs) and skin fibroblasts. In BMSCs from healthy ...